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Abstract 
Joubert syndrome (JS) is a recessive neurodevelopmental disorder characterized by a distinctive mid-
hindbrain malformation. JS is part of a group of disorders called ciliopathies, based on their overlapping 
phenotypes and common underlying pathophysiology linked to primary cilium dysfunction. Bi-allelic 
mutations in one of 28 genes, all encoding proteins localizing to the primary cilium or basal body, can 
cause JS. Despite this large number of genes, the genetic cause can currently be determined in about 62% 
of individuals with JS. To identify novel JS genes, we performed whole exome sequencing on 35 individuals 
with JS and found bi-allelic rare deleterious variants (RDVs) in KIAA0586, encoding a centrosomal protein 
required for ciliogenesis, in one individual. Targeted next-generation sequencing in a large JS cohort 
identified bi-allelic RDVs in eight additional families, for an estimated prevalence of 2.5% (9/366 JS 
families). All affected individuals displayed JS phenotypes toward the mild end of the spectrum. 
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Joubert syndrome (JS, OMIM 213300) is a recessive neurodevelopmental disorder characterized by a 
pathognomonic hindbrain malformation recognized as the “Molar Tooth sign” on axial MRI and consisting of 
cerebellar vermis hypoplasia, thickened and horizontally oriented superior cerebellar peduncles and a deep 
interpeduncular fossa (Maria et al., 1997). Clinically, individuals with JS present with abnormal eye 
movements, respiratory control disturbances, cognitive impairment, hypotonia and ataxia (Parisi and Glass, 
2003; Brancati et al., 2010). Involvement of other organ systems in various combinations is present in over 
60% of individuals with JS, including retinal dystrophy, ocular coloboma, tubulo-interstitial kidney disease, 
liver fibrosis or polydactyly (Bachmann-Gagescu et al., 2015). JS belongs to an expanding group of 
disorders collectively named ciliopathies, based on their overlapping phenotypes and common underlying 
pathophysiology linked to primary cilium dysfunction (Badano et al., 2006). Primary cilia are microtubule-
based organelles present at the surface of most differentiated cells where they are involved in transduction 
of sensory, chemical or mechanical signals (Singla and Reiter, 2006). Cilia are also required for 
transduction of signaling pathways, in particular hedgehog signaling (Goetz and Anderson, 2010), during 
development and to maintain homeostasis. Similar to other ciliopathies, JS is genetically heterogeneous, 
resulting from recessive mutations in >28 genes (one X-linked), all of which encode proteins localizing to 
the primary cilium and basal body (Romani et al., 2013). Despite this large number of genes, the causal 
mutations can currently be identified in about 62% of individuals with JS, suggesting that additional genes 
may be involved (Bachmann-Gagescu et al, 2015).  
To identify novel genetic causes of JS, we performed whole exome sequencing in a cohort of 35 
individuals with a clinical diagnosis of JS from the University of Washington (UW) Joubert Syndrome 
Research Program. Inclusion criteria comprised the presence of clinical findings of JS (intellectual 
impairment, hypotonia, ataxia and/or oculo-motor apraxia), diagnostic brain imaging findings (MTS), and 
lack of mutations in 28 JS-associated genes (NPHP1, AHI1, CEP290, RPGRIP1L, TMEM67, CC2D2A, 
ARL13B, INPP5E, OFD1, TMEM216, CEP41, TMEM237, TCTN2, KIF7, TCTN1, TMEM138, MKS1, 
C5ORF42, TMEM231, TCTN3, CSPP1, PDE6D, IFT172, ZNF423, TTC21B, B9D1, B9D2, and C2CD3) by 
targeted sequencing (O’Roak et al., 2012, Bachmann-Gagescu et al, 2015). All participants or their legal 
representatives provided written informed consent for the study, which was approved by the Institutional 
Review Boards at the UW and Seattle Children’s Hospital. Exome sequencing was performed as previously 
described (Chong et al., 2015) using Roche Nimblegen SeqCap EZ Human Exome Library v2.0 capture 
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probes (~36.5 Mb of coding exons) and paired-end 50 base pair reads on an Illumina HiSeq sequencer. In 
accordance with the Genome Analysis ToolKit’s (GATK) best practices, we mapped sequence reads to the 
human reference (hg19) using the Burrows-Wheeler Aligner (BWA v.0.6.2), removed duplicate reads 
(PicardMarkDuplicates v1.70), and performed indel realignment (GATK IndelRealigner v.1.6) and base-
quality recalibration (GATK TableRecalibration v1.6). We called variants using the GATK UnifiedGenotyper 
and flagged with VariantFiltration to mark potential false positives that did not pass the following filters: 
Heterozygous Allele Balance (ABHet) > 0.75, Quality by Depth (QD) > 5.0, Quality (QUAL) >= 50.0, 
Homopolymer Run (Hrun) < 4.0 and low depth (<6X). We used SeattleSeq for variant annotation 
(http://snp.gs.washington.edu/SeattleSeqAnnotation137/) and the Combined Annotation Dependent 
Depletion (CADD) score to determine deleteriousness of identified missense variants 
(http://cadd.gs.washington.edu/; Kircher et al, 2014). Based on CADD score data for causal variants in 
other Joubert-associated genes, we used a CADD score cutoff of 11 to define deleterious variants 
(Bachmann-Gagescu et al, 2015). 
We identified three samples that had one or more rare (minor allele frequency <1% in the exome 
variant server database (EVS; http://evs.gs.washington.edu/EVS/)), predicted-deleterious variants (RDVs) 
in KIAA0586 (NM_001244189.1): UW176-3 carries two rare predicted deleterious variants, a maternally 
inherited canonical splice site mutation (c.1413-1G>C) and a paternally inherited frameshift mutation 
(c.428delG, p.R143Kfs*4); the other genes with two rare variants in this sample only harbor missense or in-
frame deletions of 1-2 codons.UW325-3 and UW077-3 both carry the same frameshift mutation (c.428delG, 
p.R143Kfs*4). Given that KIAA0586 is the homologue of the mouse and chicken KIAA0586 (=TALPID3) 
gene, encoding a centrosomal protein required for ciliogenesis and hedgehog signaling (Bangs et al., 2011; 
Yin et al., 2009; Ben et al., 2011), and that we identified truncating mutations in three samples, we 
considered it a good candidate for further validation.  
To identify further families with /KIAA0586 mutations, we used the molecular inversion probe 
technique (O’Roak et al., 2012, Boyle, et al., 2014) to capture all exons of this gene in 366 families, 
followed by paired-end 101 base pair read sequencing on an Illumina HiSeq sequencer. Using this method, 
we identified affected individuals in nine additional families who carried two RDVs or a homozygous RDV in 
KIAA0586 (Figure 1A and Table 1). In one family, the mother carried the same homozygous p.D1360G 
missense variant that was identified in the affected child; this missense variant is present in ExAC 
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(http://exac.broadinstitute.org/) in seven control samples in the homozygous state, so we excluded this 
family from further analysis. The variants segregated appropriately in the other six families for whom we 
had parental DNA (Table 1), yielding a total of nine out of 366 families sequenced (=2.5%). In seven 
additional individuals, we identified single rare, heterozygous truncating KIAA0586 variants (Table 1). All 
mutations have been submitted to ClinVar. 
At least five isoforms are described for KIAA0586. The canonical isoform (transcript 
NM_001244189.1) encodes a protein of 1644 amino acids, with 4 coiled-coil domains (predicted by N-coil, 
Lupas et al., 1991) and one C-terminal proline-rich region (Figure 1A). UW174-3 carries a frameshift 
mutation (p.E477Gfs*7) along with a synonymous substitution near a splice site (last basepair of exon 23). 
This synonymous variant leads to use of a cryptic splice site in exon 23 and deletion of 56 basepairs 
resulting in a frameshift and premature truncation of the protein (Figure 1B). Individual UW180-3 carries a 
homozygous missense mutation (p. D566V) with a CADD score of 27.4, supporting its pathogenicity 
(Kircher et al., 2014). We detected a recurrent frameshift mutation (c.428delG, p.R143Kfs*4) in 7/9 families 
with bi-allelic mutations (and in four additional individuals as single heterozygous KIAA0586 variants). In 
1/7 families, this frameshift is present in the homozygous state, while in 4/7, it occurs with a second 
frameshift mutation, and in 2/7, it occurs with a canonical splice site mutation. R143Kfs*4 is described in 
ExAC and EVS with an allele frequency of 0.39%, but is never found homozygous in these databases, 
supporting its pathogenicity. Moreover, the prevalence of this mutation in our JS cohort (11/732 alleles = 
1.5%) is significantly increased compared to those described in ExAC or EVS (p<0.0001, Chi-square test).  
The clinical presentation of the nine affected individuals with bi-allelic KIAA0586 mutations is relatively 
homogeneous, consisting mainly of JS neurological features without other organ involvement (Table 1). 
Only UW180-3 has polydactyly, and individual UW174-3 has coloboma, but no reported retinal, renal or 
liver involvement. Individual UW174-3 also has sensorineural hearing loss and an atrial septal defect. All 
individuals have the Molar Tooth Sign (MTS) on brain MRI and additional brain anomalies include 
brainstem heterotopia in two individuals (UW174-3 and UW177-3), dysplasia of the cerebellar hemispheres 
in one individual and a thick and dysplastic corpus callosum in a fourth individual (Figure 2). Given the 
relative lack of additional clinical features and the mildly abnormal neurodevelopmental outcome of three of 
the four individuals for whom detailed information is available, it appears that KIAA0586 mutations may be 
associated with forms of JS at the mild end of the disease spectrum.  
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The identification of KIAA0586 mutations in individuals with JS fits with the extensive functional work 
in the literature. KIAA0586 protein localizes to centrioles (Kobayashi et al., 2014) and plays a role in 
centrosome migration during ciliogenesis (Yin et al., 2009; Stephen et al., 2013). Ultrastructural studies of 
chick KIAA0586 mutant cells in the neural tube demonstrated apically located centrosomes that were not 
associated with a ciliary vesicle, potentially explaining the ciliogenesis defect (Yin et al., 2009). 
Phenotypically, mice and chicks lacking KIAA0586 display typical ciliopathy phenotypes including neural 
tube patterning defects, cystic kidney disease, laterality defects and polydactyly (Davey et al., 2006; Bangs 
et al., 2011). Originally, the association of limb patterning and neural tube defects in the chick KIAA0586 
mutant was linked to disrupted hedgehog signaling (Davey et al., 2006), and this is consistent with the now 
well-documented role of primary cilia in hedgehog signaling (Goetz and Anderson, 2010). Given the 
pervasive polydactyly in animal models and other data demonstrating a key role for KIAA0586 in sonic 
hedgehog signaling, it is surprising that only one of nine individuals (11%) has polydactyly, compared to 
19% in our large cohort of individuals with JS (Doherty, 2009). Likewise, the nine individuals with 
KIAA0586-related JS in this study are relatively mildly affected compared to what would be expected from a 
major ciliogenesis defect, therefore suggesting that either KIAA0586 is less important for development in 
humans compared to animal models, or that the mutations identified in our cohort are hypomorphic. In 
summary, we show that bi-allelic KIAA0586 mutations are associated with relatively mild JS in ~2.5% of 
families with JS. 
 
Addendum: During the review process, Roosing et al published mutations in KIAA0586 as a cause of 
Joubert syndrome (Roosing et al., 2015). 
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Figure Legends 
Figure 1. (A) KIAA0586 protein ideogram with schematic position of the identified mutations. Mutations on 
the top row were identified in individuals with bi-allelic KIAA0586 RDVs, while those in the bottom row were 
identified in individuals with only single heterozygous KIAA0586 RDVs. (B) Splicing studies for the 
synonymous-near-splice mutation detected in UW174-3. cDNA was generated (iScriptTM Reverse 
Transcription Kit, Bio-Rad) using total RNA isolated from control and UW174-3 fibroblasts (the AurumTM 
Total RNA Mini Kit, Bio-Rad). RT-PCR using the exon 22-24* primer pair (arrows in lower panel) showing a 
single, appropriately-sized product from the control (“C”), and two products, one appropriately-sized and 
another approximately 50bp shorter, from UW174-3. No difference in PCR product size is observed 
between the control and UW174-3 using the exon 22-23* primer pair (B, upper). Sequence tracings of the 
shorter PCR product from UW174-3 following gel extraction (QIAquick Gel Extraction Kit, QIAGEN) 
revealing a 56bp deletion of the 3’ portion of exon 23 compared to the control (B, middle). The longer PCR 
product sequence from UW174-3 was concordant with the control sequence (data not shown). A diagram 
of the altered exon splicing resulting from the synonymous-near-splice mutation in UW174-3 (B, lower). The 
red bar indicates the 56bp sequence removed by aberrant splicing. The predicted PCR product sizes 
include an additional 36bp due to the use of M13 universal sequencing primers for the PCRs. *Primer 
sequences available upon request. 
Figure 2. Brain imaging features in individuals with KIAA0586-related Joubert syndrome. (A-C) Molar 
tooth sign (A) and long superior cerebellar peduncles (B-C). (D-F) superior cerebellar dysplasia. (G-I) 
Elevated roof of the 4th ventricle (G and I) and superior cerebellar peduncle (H). Images for UW175-3 are 
presented in panels (A, D, G), UW177-3 in (B, E), UW179-3 in (C,F), UW174-3 in (H), and UW181-3 in (G). 
Panels (A, B, D, E) are axial T2-weighted images, (C, F) are axial T1-weighted images, (G) is sagittal T2-
weighted, and (H, I) are sagittal T1-weighted. 
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Table 1. Clinical features in patients with KIAA0586-related Joubert syndrome 
Biallelic 
RDVs 
Mutation 1 
KIAA0586 
Mutation 2 
KIAA0586 
Age 
(yrs) DD 
Other brain 
anomalies A/T 
Abnl eye 
mvts Retina Colob Kidney Liver PD Other 
Reported 
ethnicity 
Additional RDVs 
in other JS 
genes 
UW173-4 c.428delG p.R143Kfs*4 (m) 
c.1413-1G>C 
p.? (p) 22 mod - A+T NA - - - - -  Mixed EU 
htz IFT172 
p.R1134L 
UW174-3 Indel
1 
p.E477Gfs*7 (m) 
r.3248_3303del4 
p.P1084Kfs*22 (?) 9 sev CM het A+T + NA + - - - 
SNHL 
ASD Asian (Laos) - 
UW175-3 c.428delG p.R143Kfs*4 (m) 
c.1159C>T 
p.Q387* (?) 9 NA 
Cb 
dysplasia A+T + - - - - -  
Fr CA/Native Am/ 
Mixed EU - 
UW176-3 c.428delG p.R143Kfs*4 (p) 
c.1413-1G>C 
p.? (m) 5 mild  - + - - - - -  Mixed EU - 
UW177-3 c.428delG p.R143Kfs*4 (p) 
c.428delG 
p.R143Kfs*4 (m) 4 NA 
Midbrain 
het T + - - - - -  
Middle Eastern 
(Lebanon) 
htz C5ORF42 
p.T1598K 
UW178-3 c.428delG p.R143Kfs*4 (?) 
c.863_864delAA 
p.Q288Rfs*7 (?) 10 NA  NA NA NA NA NA NA NA  Latino (Brazil) - 
UW179-3 c.1730_1734delTATCT p.L577Yfs*10 (m) 
c.428delG 
p.R143Kfs*4 (p) 8 mild  - + - - - - -  EU (Spain) - 
UW180-3 c.1697A>T p.D566V (p) 
c.1697A>T 
p.D566V (m) 2 NA  - NA -  - - +  
Middle Eastern 
(Turkey) - 
UW181-3 c.428delG p.R143Kfs*4 (p) 
c.802C>T 
p.Q268* (m) 5 mild dyspl CC A+T + - - - - -  EU (UK) - 
               
Single RDVs               
UW324-3 c.4236_4239delTCTC p.L1413Ifs*43 (p)  23 NA   NA - + - NA - 
Pyloric 
stenosis Mixed EU 
htz TCTN3 
p.Q357R 
UW325-3 c.428delG p.R143Kfs*4 (m)  17 NA   + - NA - - -  Mixed EU - 
UW077-3 c.428delG p.R143Kfs*4 (m)  16 mild   + - - - - - 
sz, ADHD, 
PDD AA/mixed EU - 
UW096-3 c.3614G>A p.W1205* (?)  10 NA   NA + NA NA - + 
Jeune 
absent R 
12th rib 
Trinidad, Jamaica 
htz C2CD3 
p.1832G and 
p.G1831W3 
UW326-3 c.428delG p.R143Kfs*4 (?)  Unk NA   NA NA NA NA NA NA  
Middle Eastern 
(Turkey) - 
UW327-3 c.130dupC p. H44Pfs*8(?)  14
2 sev   NA NA NA - - - Autism, self-inj, O2 Hispanic - 
UW328-3 c.2663_2667delTGTCT p.L888Qfs*24 (m)  4 mild   + - + - - - GH Mixed EU 
htz AHI1  
p.Y933C 
1c.1430_1434delAGCTAinsGAAG; 2deceased; 3heterozygous C2CD3 variants in cis; 4chr14:g.58949430G>A, c.3303G>A 
A: Apnea, AA: African American, Abnl: Abnormal, ADHD: Attention Deficit Hyperactivity Disorder, ASD Atrial Septal Defect, Cb: Cerebellar, CC: corpus callosum, CM: 
Cervicomedullary, Colob: coloboma, DD: Developmental Disability, EU: European, inj: injury, mod: moderate, Fr CA: French Canadian, MTS: Molar Tooth Sign, mvts 
movements, NA: not available, O2: supplemental oxygen, PD polydactyly, PDD: pervasive developmental disorder, R: right, sev: severe, SNHL: sensorineural hearing loss, 
spl: splice site, T: Tachypnea UK: United Kingdom, Unk: unknown, htz heterozygous. 
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(m) maternal allele, (p) paternal allele, (?): unknown parental origin 
The common frameshift mutation is indicated in bold. cDNA and protein positions are indicated based on transcript ENST00000619416, NM_001244189. 
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